Updated Jul 16, 2026
Stewart Robert A is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Robert A. Stewart is listed as a director of CorMedix Inc. (CRMD), a U.S. biopharmaceutical company focused on life-threatening disease therapeutics and DefenCath. In the most recent SEC filing dated January 28, 2026, Stewart is reported as a director with no stock purchases or sales in that filing, indicating no disclosed insider transactions for that period.
| Role | Director |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-28 | CRMD | CorMedix Inc. | A — Grant or award | 30.5K | $0.00 |
Robert A. Stewart is listed as a director of CorMedix Inc. (CRMD), a U.S. biopharmaceutical company focused on life-threatening disease therapeutics and DefenCath. In the most recent SEC filing dated January 28, 2026, Stewart is reported as a director with no stock purchases or sales in that filing, indicating no disclosed insider transactions for that period.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Stewart Robert A profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.